# A03-025 - Pharmacodynamic Modeling

## Program

Program A03 - Scientific Content Population: SSRIs.

## Phase

Phase 3 - Drug Scientific Modeling.

## Mission

Create the official structural layer for pharmacodynamic modeling.

## Scope Executed

This mission created pharmacodynamic model shells for the six core SSRIs.

## Created Artifacts

- `KnowledgeBase/SSRIs/Pharmacodynamics/PD_SCHEMA.json`
- `KnowledgeBase/SSRIs/Pharmacodynamics/PD_MODEL.json`
- `KnowledgeBase/SSRIs/Pharmacodynamics/PD_INDEX.json`
- `KnowledgeBase/SSRIs/Pharmacodynamics/PD_TRACEABILITY.json`
- `KnowledgeBase/SSRIs/Pharmacodynamics/PD_VALIDATION.json`
- `KnowledgeBase/SSRIs/Pharmacodynamics/PD_MANIFEST.json`

## PD Structure

The schema supports:

- primary pharmacodynamic effect;
- secondary pharmacodynamic effects;
- synaptic effect;
- neuroplasticity effect;
- adaptive changes;
- downstream effects;
- delayed effects;
- persistent effects;
- clinical correlation as structure only;
- mechanism relationship.

## Modeling Boundary

No pharmacodynamic values were extracted or interpreted in this mission.

Each value-bearing field is marked as `pending_field_extraction`.

Clinical correlation is present only as a future structural placeholder and does not contain clinical guidance.

## Traceability

Traceability uses:

- `KnowledgeBase/SSRIs/Traceability/DRUG_SOURCE_BINDING.json`
- `ScientificCorpus/Metadata/NORMALIZED_SOURCE_REGISTRY.json`

## Explicit Non-Scope

This mission did not create:

- dose;
- titration;
- clinical indication;
- contraindication;
- safety content;
- interaction content;
- monitoring;
- recommendation;
- prescription;
- runtime rule;
- Clinical Kernel behavior;
- Decision Engine behavior;
- Therapeutic Optimization behavior.

## Next Mission

`A03-026 - INDICATION_MODELING`

## Declaration Final

A03-025 created pharmacodynamic structures only. It remains non-prescriptive, non-runtime and pending future field-level scientific extraction.
